CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Mesna

美司钠 杂质对照品Mesna Impurities

EP32 个杂质条目32 impurity entries

本页汇总 美司钠 的 32 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 32 impurity reference standards of Mesna with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 美司钠(Mesna)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesValidated stability-indicating HPLC method for the determination of mesna in presence of its degradation products
    Journal of chromatographic science · 2015 · Rizk M et al.  ·  PMID 25238767  ·  DOI
  2. 杂质研究Impurity studiesNew investigations into the stability of Mesna using LC-MS/MS and NMR
    Expert review of anticancer therapy · 2016 · Salman D et al.  ·  PMID 26568378  ·  DOI
  3. 杂质研究Impurity studiesStability of cyclophosphamide and mesna admixtures in polyethylene infusion bags
    The Annals of pharmacotherapy · 2003 · Menard C et al.  ·  PMID 14632591  ·  DOI
  4. 分析方法Analytical MethodsFabrication of impedimetric sensor based on metallic nanoparticle for the determination of mesna anticancer drug
    Scientific reports · 2023 · Mehrban M et al.  ·  PMID 37452101  ·  DOI
  5. 分析方法Analytical MethodsPhysical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2014 · Zhang Y et al.  ·  PMID 23512269  ·  DOI

美司钠 —— 原料药与杂质对照品Mesna — drug substance & impurities

共 33 个条目(含原料药本体)33 items incl. the drug substance
Mesna structure
EP原料药 APIAPI
美司钠Mesna
Mesna
CAS No.19767-45-4
Chemical FormulaC2H5O3S2-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 1(Mesna EP Impurity A) structure
EPA
美司钠杂质1(美司钠EP杂质A)Mesna Impurity 1(Mesna EP Impurity A)
Mesna Impurity 1(Mesna EP Impurity A)
CAS No.25985-57-3
Chemical FormulaC3H8N2O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 2 (Mesna EP Impurity B) structure
EPB
美司钠杂质2 (美司钠EP杂质B)Mesna Impurity 2 (Mesna EP Impurity B)
Mesna Impurity 2 (Mesna EP Impurity B)
CAS No.1391053-66-9
Chemical FormulaC4H10N4O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 3(Mesna EP Impurity C) structure
EPC
美司钠杂质3(美司钠EP杂质C)Mesna Impurity 3(Mesna EP Impurity C)
Mesna Impurity 3(Mesna EP Impurity C)
CAS No.69536-71-6
Chemical FormulaC4H8O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 3 Sodium Salt(Mesna EP Impurity C Sodium Salt) structure
EPC
美司钠杂质3 钠盐(美司钠EP杂质C 钠盐)Mesna Impurity 3 Sodium Salt(Mesna EP Impurity C Sodium Salt)
Mesna Impurity 3 Sodium Salt(Mesna EP Impurity C Sodium Salt)
CAS No.76274-71-0
Chemical FormulaC4H7O4S2-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 4(Mesna EP Impurity D) structure
EPD
美司钠杂质4(美司钠EP杂质D)Mesna Impurity 4(Mesna EP Impurity D)
Mesna Impurity 4(Mesna EP Impurity D)
CAS No.16208-51-8
Chemical FormulaC4H8Na2O6S4
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 4 Monomer(Mesna EP Impurity D Monomer) structure
EPD
美司钠杂质4 单体(美司钠EP杂质D 单体)Mesna Impurity 4 Monomer(Mesna EP Impurity D Monomer)
Mesna Impurity 4 Monomer(Mesna EP Impurity D Monomer)
CAS No.45127-11-5
Chemical FormulaC4H10O6S4
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 5(Mesna EP Impurity E) structure
EPE
美司钠杂质5(美司钠EP杂质E)Mesna Impurity 5(Mesna EP Impurity E)
Mesna Impurity 5(Mesna EP Impurity E)
CAS No.1391054-56-0
Chemical FormulaC5H9N5O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Monomer structure
—
美司钠 单体Mesna Monomer
Mesna Monomer
CAS No.3375-50-6
Chemical FormulaC2H6O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 6 structure
6
美司钠杂质6Mesna Impurity 6
Mesna Impurity 6
CAS No.41239-91-2
Chemical FormulaC3H7BrO3S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 7 structure
7
美司钠杂质7Mesna Impurity 7
Mesna Impurity 7
CAS No.41239-92-3
Chemical FormulaC4H9BrO3S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 8 structure
8
美司钠杂质8Mesna Impurity 8
Mesna Impurity 8
CAS No.1709792-04-0
Chemical FormulaC3H8O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 10 structure
10
美司钠杂质10Mesna Impurity 10
Mesna Impurity 10
CAS No.90663-51-7
Chemical FormulaC4H10O4S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 11 structure
11
美司钠杂质11Mesna Impurity 11
Mesna Impurity 11
CAS No.10307-29-6
Chemical FormulaC3H7ClO3S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 12 structure
12
美司钠杂质12Mesna Impurity 12
Mesna Impurity 12
CAS No.25372-93-4
Chemical FormulaC4H9ClO3S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 13 structure
13
美司钠杂质13Mesna Impurity 13
Mesna Impurity 13
CAS No.41239-88-7
Chemical FormulaC6H13ClO3S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 14 structure
14
美司钠杂质14Mesna Impurity 14
Mesna Impurity 14
CAS No.500692-41-1
Chemical FormulaC6H14O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 15 structure
15
美司钠杂质15Mesna Impurity 15
Mesna Impurity 15
CAS No.1823982-49-5
Chemical FormulaC4H9N3O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 17 structure
17
美司钠杂质17Mesna Impurity 17
Mesna Impurity 17
CAS No.1633-84-7
Chemical FormulaC4H8Cl2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 18 structure
18
美司钠杂质18Mesna Impurity 18
Mesna Impurity 18
CAS No.113309-30-1
Chemical FormulaC4H9ClO3S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 19 structure
19
美司钠杂质19Mesna Impurity 19
Mesna Impurity 19
CAS No.70105-61-2
Chemical FormulaC4H8ClNaO3S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 19 Monomer structure
19
美司钠杂质19 单体Mesna Impurity 19 Monomer
Mesna Impurity 19 Monomer
CAS No.74304-26-0
Chemical FormulaC4H9ClO3S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 20  Disodium Salt structure
20
美司钠杂质20 二钠盐Mesna Impurity 20 Disodium Salt
Mesna Impurity 20 Disodium Salt
CAS No.1110574-95-2
Chemical FormulaC5H8O7S42-·2Na+
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 20 structure
20
美司钠杂质20Mesna Impurity 20
Mesna Impurity 20
CAS No.1110813-35-8
Chemical FormulaC5H10O7S4
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 22 structure
22
美司钠杂质22Mesna Impurity 22
Mesna Impurity 22
CAS No.750554-94-0
Chemical FormulaC12H25BrO3S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 23 Disodium Salt structure
23
美司钠杂质23 二钠盐Mesna Impurity 23 Disodium Salt
Mesna Impurity 23 Disodium Salt
CAS No.187142-21-8
Chemical FormulaC5H10N2O6S32-·2Na+
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 23 structure
23
美司钠杂质23Mesna Impurity 23
Mesna Impurity 23
CAS No.742040-90-0
Chemical FormulaC5H12N2O6S3
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 24 structure
24
美司钠杂质24Mesna Impurity 24
Mesna Impurity 24
CAS No.130138-93-1
Chemical FormulaC4H10O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 25 structure
25
美司钠杂质25Mesna Impurity 25
Mesna Impurity 25
CAS No.173459-89-7
Chemical FormulaC4H10O5S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 26 structure
26
美司钠杂质26Mesna Impurity 26
Mesna Impurity 26
CAS No.20305-86-6
Chemical FormulaC2H6O4S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 27 structure
27
美司钠杂质27Mesna Impurity 27
Mesna Impurity 27
CAS No.18024-00-5
Chemical FormulaC2H5ClO3S
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 31 structure
31
美司钠杂质31Mesna Impurity 31
Mesna Impurity 31
CAS No.64426-00-2
Chemical FormulaC4H10O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Mesna Impurity 32 structure
32
美司钠杂质32Mesna Impurity 32
Mesna Impurity 32
CAS No.110-04-3
Chemical FormulaC2H6O6S2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

美司钠 —— 研究文献与合成路线Mesna — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 美司钠 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Mesna. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Validated stability-indicating HPLC method for the determination of mesna in presence of its degradation products
    Rizk M, Taha EA, Mowaka S, et al. · Journal of chromatographic science · 2015 · 被引 4cited 4

合成与制备工艺专利Synthesis & process patents

  1. Method for preparing mesna
    XINZENG WANG, CHUNHUA JIN · 公开号 CN101628887CN101628887 · 2010
  2. Ifosfamide-mesna lyophilizate and process for its preparation
    SAUERBIER DIETER, ISAAC OTTO, BRADE WOLFGANG P · 公开号 US4959215US4959215 · 1990
  3. Ifosfamide/mesna lyophilisate and process for its production
    SAUERBIER DIETER, ISAAC OTTO DR, BRADE WOLFGANG PETER DR · 公开号 DE3907079DE3907079 · 1989

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

美司钠 杂质谱研究要点Mesna — impurity profiling notes

下面这些是拿到 美司钠 的 33 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 33 impurity entries for Mesna, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances